CLB vs XOM

For growth investors, Core Laboratories N.

V. (CLB) is the stronger pick with 0. 5% revenue growth year-over-year, versus -4. 5% for Exxon Mobil Corporation (XOM). Core Laboratories N. V. (CLB) offers the better valuation at 18. 7x trailing P/E (21. 2x forward), making it the more compelling value choice. Analysts rate Core Laboratories N. V. (CLB) a "Hold" — based on 37 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Core Laboratories N.

V. (CLB) is the cheapest at 18. 7x versus Exxon Mobil Corporation at 21. 0x. On forward P/E, Exxon Mobil Corporation is actually cheaper at 12. 9x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Exxon Mobil Corporation (XOM) delivered a total return of +148.

5%, compared to -71. 5% for Core Laboratories N. V. (CLB). Over 10 years, the gap is even starker: XOM returned +95. 6% versus CLB's -83. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Exxon Mobil Corporation (XOM) is the lower-risk stock at -0.

37β versus Core Laboratories N. V. 's 0. 96β — meaning CLB is approximately -357% more volatile than XOM relative to the S&P 500. On balance sheet safety, Exxon Mobil Corporation (XOM) carries a lower debt/equity ratio of 16% versus 74% for Core Laboratories N. V. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Core Laboratories N.

V. (CLB) is pulling ahead at 0. 5% versus -4. 5% for Exxon Mobil Corporation (XOM). On earnings-per-share growth, the picture is similar: Core Laboratories N. V. grew EPS 3. 0% year-over-year, compared to -14. 5% for Exxon Mobil Corporation. Over a 3-year CAGR, CLB leads at 2. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Exxon Mobil Corporation (XOM) is the more profitable company, earning 8.

9% net margin versus 6. 0% for Core Laboratories N. V. — meaning it keeps 8. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: XOM leads at 10. 5% versus 9. 3% for CLB. At the gross margin level — before operating expenses — XOM leads at 21. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Exxon Mobil Corporation (XOM) trades at 12.

9x forward P/E versus 21. 2x for Core Laboratories N. V. — 8. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CLB: 96. 5% to $25. 00.

All stocks in this comparison pay dividends.

Exxon Mobil Corporation (XOM) offers the highest yield at 2. 8%, versus 0. 3% for Core Laboratories N. V. (CLB).

For long-horizon retirement investors, Exxon Mobil Corporation (XOM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

37), 2. 8% yield). Both have compounded well over 10 years (XOM: +95. 6%, CLB: -83. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Energy sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

XOM pays a dividend while CLB does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.